Cargando…

Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer

The most common thyroid malignancy is papillary thyroid cancer (PTC). Mortality rates from PTC mainly depend on its aggressiveness. Geno- and phenotyping of aggressive PTC has advanced our understanding of treatment failures and of potential future therapies. Unraveling molecular signaling pathways...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benvenga, Salvatore, Koch, Christian A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064555/ https://www.ncbi.nlm.nih.gov/pubmed/24955023 http://dx.doi.org/10.2174/1389202915999140404100958

Ejemplares similares

Molecular features of aggressive thyroid cancer
por: Elia, Giusy, et al.
Publicado: (2022)

New Therapies for Dedifferentiated Papillary Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2015)

LGR5 is associated with tumor aggressiveness in papillary thyroid cancer
por: Michelotti, Gregory, et al.
Publicado: (2015)

Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness
por: So, Anthony K.-C., et al.
Publicado: (2012)

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma
por: Teng, Huajing, et al.
Publicado: (2018)

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas
por: Jin, Meihua, et al.
Publicado: (2021)

The indices of body size and aggressiveness of papillary thyroid carcinoma
por: Kim, Ju-Yeon, et al.
Publicado: (2011)

Molecular Targeted Therapies of Aggressive Thyroid Cancer
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Management of the Patient with Aggressive and Resistant Papillary Thyroid Carcinoma
por: Miftari, Rame, et al.
Publicado: (2016)

Aggressive Papillary Thyroid Carcinoma Presenting with Metastasis to the Pancreas
por: Warda, Firas, et al.
Publicado: (2022)

Low Vitamin D Status is Not Associated with the Aggressive Pathological Features of Papillary Thyroid Cancer
por: Demircioglu, Zeynep Gul, et al.
Publicado: (2022)

Aggressive fibromatosis-associated with papillary thyroid cancer: two cases and a brief review
por: Li, Yao, et al.
Publicado: (2019)

Multimodality MRI-based radiomics for aggressiveness prediction in papillary thyroid cancer
por: Dai, Zedong, et al.
Publicado: (2022)

Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter
por: Fama, Fausto, et al.
Publicado: (2018)

One-third of an Archivial Series of Papillary Thyroid Cancer (Years 2007–2015) Has Coexistent Chronic Lymphocytic Thyroiditis, Which Is Associated with a More Favorable Tumor-Node-Metastasis Staging
por: Ieni, Antonio, et al.
Publicado: (2017)

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways
por: Zhang, Jinjun, et al.
Publicado: (2018)

Editorial: Dietary supplements for preserving thyroid health: the scientific evidence-based view
por: Unfer, Vittorio, et al.
Publicado: (2023)

Relationship Between Thyroid-Stimulating Hormone Level and Aggressive Pathological Features of Papillary Thyroid Cancer
por: Demircioglu, Zeynep Gul, et al.
Publicado: (2022)

Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative Review
por: Coca-Pelaz, Andrés, et al.
Publicado: (2020)

Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma
por: Fu, Hongliang, et al.
Publicado: (2016)

Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma
por: Zhou, Yi-Li, et al.
Publicado: (2018)

INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression
por: Guan, Hongyu, et al.
Publicado: (2018)

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways: Erratum
por: Zhang, Jinjun, et al.
Publicado: (2023)

Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma
por: Ding, Jinhua, et al.
Publicado: (2020)

Editorial: The Association of Other Autoimmune Diseases in Patients With Thyroid Autoimmunity
por: Antonelli, Alessandro, et al.
Publicado: (2018)

The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness
por: Sheikh-Ahmad, Mohammad, et al.
Publicado: (2023)

Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
por: Lee, Cho Rok, et al.
Publicado: (2017)

Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm
por: Lee, Jin Seok, et al.
Publicado: (2022)

Relationships between serum levels of vitamins and papillary thyroid cancer: a single center case-control study
por: Zhang, Daqi, et al.
Publicado: (2023)

Exploring Somatic Alteration Associating With Aggressive Behaviors of Papillary Thyroid Carcinomas by Targeted Sequencing
por: Li, Yi, et al.
Publicado: (2021)

TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma
por: Nie, Xilin, et al.
Publicado: (2023)

Lymph node metastasis‐dependent molecular classification in papillary thyroid carcinoma defines aggressive metastatic outgrowth
por: Seo, Dong Hyun, et al.
Publicado: (2023)

GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers
por: Lee, Jandee, et al.
Publicado: (2015)

Recurrent Aggressive Fibromatosis Coexisting With Papillary Carcinoma Thyroid – Case Report
por: BG, Bharath, et al.
Publicado: (2023)

Hashimoto's Thyroiditis: Similar and Dissimilar Characteristics in Neighboring Areas. Possible Implications for the Epidemiology of Thyroid Cancer
por: Latina, Adele, et al.
Publicado: (2013)

Is aggressive digital papillary adenocarcinoma really aggressive digital papillary adenocarcinoma?
por: Chen, Sheng, et al.
Publicado: (2014)

Clinical Outcome, Role of BRAF(V600E), and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer?
por: Nucera, Carmelo, et al.
Publicado: (2012)

Pretreatment BMI Is Associated with Aggressive Clinicopathological Features of Papillary Thyroid Carcinoma: A Multicenter Study
por: Yu, Shi-tong, et al.
Publicado: (2017)

Gender-specific correlation of intranodular chronic lymphocytic thyroiditis with thyroid nodule size, echogenicity, and histologically-verified cytological class of malignancy risk
por: Arena, Salvatore, et al.
Publicado: (2018)

Magnetic resonance imaging in the prediction of aggressive histological features in papillary thyroid carcinoma
por: Song, Bin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_be4fv63nuj324njros1du017ep